AVBP
ArriVent BioPharma, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -14.3% ·
share flow -12.4% ·
net new positions -16.7%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | +1 | 67.09K | $2.03M | +1 | n/a |
| Q2 2026 | 67 | +6 | 17.31M | $600.66M | +10 | −4 |
| Q1 2026 | 63 | +7 | 15.17M | $349.66M | +10 | −3 |
| Q4 2025 | 56 | +3 | 14.51M | $292.04M | +3 | n/a |
| Q3 2025 | 14 | +1 | 10.75M | $198.25M | +2 | −1 |
| Q2 2025 | 10 | 0 | 7.02M | $152.80M | +2 | −2 |
| Q1 2025 | 7 | +1 | 1.69M | $31.28M | +2 | −1 |
| Q4 2024 | 6 | -1 | 1.52M | $40.62M | +1 | −2 |
| Q3 2024 | 6 | +4 | 925.82K | $21.76M | +4 | n/a |
| Q2 2024 | 2 | n/a | 247.05K | $4.58M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 814.09K | n/a | $21.69M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 596.18K | -0.2% | $15.89M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 3 | Millennium Management ✦ | 52.55K | -75.7% | $1.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 41.92K | New | $1.12M | 0.0% | New | 1 | SEC ↗ ×2 |
| 5 | T. Rowe Price ✦ | 10.96K | +17.3% | $293,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 8.87K | +2.4% | $236,244 | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Wellington Management | $1.12M | 0.0% |
Exited
| Marshall Wace | $2.00M | was 0.0% |
| D. E. Shaw & Co. | $206,213 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 138 holders, 42.02M shares, $965.37M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.